You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR WESTCORT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for WESTCORT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00186628 ↗ Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed National Cancer Institute (NCI) Phase 2 2005-06-01 To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD)
NCT00186628 ↗ Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed The Leukemia and Lymphoma Society Phase 2 2005-06-01 To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD)
NCT00186628 ↗ Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed Stanford University Phase 2 2005-06-01 To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD)
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for WESTCORT

Condition Name

Condition Name for WESTCORT
Intervention Trials
Leukemia, Mast-Cell 1
Mantle-cell Lymphoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for WESTCORT
Intervention Trials
Lymphoma, Mantle-Cell 1
Leukemia, Mast-Cell 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for WESTCORT

Trials by Country

Trials by Country for WESTCORT
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for WESTCORT
Location Trials
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for WESTCORT

Clinical Trial Phase

Clinical Trial Phase for WESTCORT
Clinical Trial Phase Trials
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for WESTCORT
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for WESTCORT

Sponsor Name

Sponsor Name for WESTCORT
Sponsor Trials
The Leukemia and Lymphoma Society 1
Stanford University 1
National Cancer Institute (NCI) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for WESTCORT
Sponsor Trials
Other 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.